Small cell lung cancer: Navigating the global clinical trial landscape

Clinical Trials Arena December 16, 2024
GlobalData

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of small cell lung cancer.

Small cell lung cancer is a fast-growing and aggressive subtype of lung cancer, accounting for approximately 10-15% of all lung cancer cases globally. Small cell lung cancer is divided into limited-stage and extensive-stage based on disease spread. Its aggressive nature causes early metastasis to organs like the liver, bones, brain, and adrenal glands, leading to poor prognosis.

The five-year survival rate is less than 5% for extensive-stage and 15-25% for limited-stage. Small cell lung cancer is primarily caused by long-term tobacco exposure, leading to mutations...

Today's Sponsors

Today's Sponsor